Xconomy

SEPTEMBER 5, 2017

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland. In addition to deals. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Invest 88

Invest Funding San Diego Venture Capital 88

Xconomy

MARCH 13, 2018

His investments include Synthego , a provider of technology used in CRISPR genome editing and research. At Intel Capital in the Bay Area, investment director Ranjeet Alexis is an expert in bioinformatics who is scouting for deals at the intersection of computation, healthcare, and the life sciences.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

Xconomy

MAY 31, 2017

One of them is a San Antonio researcher hoping to use gene therapy—a potentially one-time, long lasting treatment—to do the trick. When cells in the pancreas , known as beta cells, either get destroyed by the immune system.

Research 58

Research Funding San Diego Company 58

Xconomy

FEBRUARY 6, 2020

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Hurry, our $99 early bird sale ends this Friday, Feb. 7 at midnight. Speakers include Jay Lichter, CEO of.

Conference 49

Conference San Diego Sales Research 49

Xconomy

DECEMBER 4, 2019

Scientists gathered this week in San Diego at the annual Clinical Trials on Alzheimer’s Disease Congress are focused on ways to treat the neurodegenerative disease, a task that continues to vex those working to develop potential medicines.

San Diego 75

San Diego Funding Tool Ideas 75

Xconomy

JUNE 14, 2018

New immunotherapy approaches to cancer treatment, and the CRISPR technology for editing genetic material in cells, are among the most sophisticated research strategies scientists are using in their quest to defeat disease.

Research 74

Research Software Engineering Software Technology 74

Xconomy

JUNE 22, 2016

Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems. So far, Radicle has closed on $6 million in funding, and the accelerator expects its pot will reach up to $15 million.

Funding 68

Funding Research San Diego Incubator 68

Xconomy

NOVEMBER 6, 2019

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country.

Artificial Inteligence 87

Artificial Inteligence Funding Research Sites 87

Xconomy

MAY 30, 2017

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients.

Arcturus 65

Arcturus San Diego Research Funding 65

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts.

San Diego 61

San Diego Marketing Research Invest 61

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

JANUARY 3, 2018

Responses from individuals in Seattle and San Diego touch on the rapid advance of machine learning, tech’s full-scale invasion of digital health, dramatic growth in blockchain and cryptocurrency, an outpouring of private support for computer science at University of Washington (perennially a top recipient of federal research funding), and the spreading (..)

Artificial Inteligence 68

Artificial Inteligence Develop Development Social Media 68

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA.

San Diego 102

San Diego Funding Develop Development 102

Xconomy

MARCH 13, 2018

Crinetics Pharmaceuticals , a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 million in a Series B financing led by Perceptive Advisors, the New York biotech fund. In a statement Tuesday, Crinetics said it plans.

San Diego 49

San Diego Research Funding Capital 49

Xconomy

OCTOBER 13, 2017

The idea in 2011 was to create a space at what was then Johnson & Johnson’s pharmaceutical research and development facility in San Diego for an “innovation center,” a place where 18 to 20 life sciences startups could incubate, replete with lab space and equipment.

San Diego 75

San Diego Incubator Screening Research 75

Xconomy

APRIL 15, 2020

Some of the targets in cancer research are visible and well known, but they’re hard to hit with new drugs all the same. PIC Therapeutics is developing medicines aiming for one particularly elusive group of proteins, and the startup’s early research has attracted financial support from some prominent names in the life sciences industry.

Research 91

Research Invest Funding Develop 91

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

Xconomy

APRIL 17, 2020

In the real world, the journey to a vaccine OK’d under emergency guidelines is more likely to take 12 to 18 months, said Marks, who runs the FDA’s Center for Biologics Evaluation and Research, on a Friday teleconference hosted by the Commonwealth Fund and the Alliance for Health Policy Teleconference for Media and Policymakers.

Marketing 93

Marketing Research Media Ideas 93

Xconomy

AUGUST 30, 2016

UC San Diego has named Todd Hylton, a veteran tech industry manager and expert in neural-based processing technology, as executive director of its new Contextual Robotics Institute. Hylton was previously the executive vice president of strategy and research at Brain Corp.,

UCSD 49

UCSD San Diego Artificial Inteligence Research 49

Xconomy

JUNE 10, 2018

CureMatch , a San Diego startup with technology to help doctors choose the best combination of anti-cancer treatments based on an analysis of each patient’s tumor, took home a $35,000 grant intended to help companies expand overseas. CureMatch was the top vote-getter among four finalists that.

San Diego 72

San Diego Startup Organization Help 72

Xconomy

SEPTEMBER 27, 2016

[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m. Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

APRIL 10, 2020

The coronavirus research is expected. Startups are raising money, and there is more financing on the way as investment firms close new funds. The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector.

Activity 103

Activity Research Invest Startup 103

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

MAY 15, 2017

San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). Founding CEO Kevin Lustig said Scientist.com will use the additional cash to expand its operations. Lustig argued.

Outsource 79

Outsource Marketing Research Web 79

Xconomy

MARCH 2, 2020

With one investigational cancer drug in Phase 1 testing and a second one approaching the clinic, ORIC Pharmaceuticals is looking to tap the public markets for funds to finance that research.

Study 90

Study Research Funding Marketing 90

Xconomy

JULY 2, 2019

The year was 1972: three years after the first messages were firing across the US military-funded research network ARPANET, the precursor to the internet, but still more than a decade before the internet’s architects settled on rules for how information would be transmitted across the network.

.Net 97

.Net Research Networking Santa Barbara 97

Xconomy

NOVEMBER 6, 2017

The San Diego company, founded a decade ago on 3D bio-printing technology developed by the University of Missouri’s Gabor Forgacs, appeared to be gaining momentum on multiple fronts.

Outsource Development 49

Outsource Development San Diego Sample Screening 49

Xconomy

OCTOBER 22, 2018

San Diego-based Qpex has raised $33 million to advance The Medicines Company’s (NASDAQ: MDCO ) old preclinical compounds toward human testing. The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics.

San Diego 86

San Diego Company Companies Develop 86

Xconomy

SEPTEMBER 5, 2018

The Los Angeles-based firm is led by managing directors Beth Seidenberg, a former general partner at venture capital firm Kleiner Perkins, and Sean Harper, the outgoing executive vice president of research and development at Amgen (NASDAQ: AMGN ). Harper will start with Westlake in January after retiring from Amgen.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Xconomy

MAY 24, 2019

Inhibrx, developer of protein drugs targeting cancer and other diseases, has raised $40 million from the hedge fund Viking Global Investors as the biotech steers several programs through early-stage clinical trials. The La Jolla, CA-based company was founded in 2010 by Mark Lappe, Brendan Eckelman, and Quinn Deveraux.

Press 67

Press Research Funding Invest 67

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund.

San Diego 40

San Diego Avalon Research Examples 40

Xconomy

JUNE 26, 2018

But that is starting to change, as Asian cities—particularly in China—are snapping up more tech venture capital funding and exits, according to a new report from CB Insights. But Beijing and Shanghai startups appear to be working to keep pace, reeling in $72.

Startup 84

Startup Report Venture Capital Research 84

Xconomy

SEPTEMBER 6, 2016

After signaling that it plans to operate drones via cellular technologies, San Diego-based Qualcomm says today it is working with AT&T to use commercial wireless networks for test flights beyond an operator’s visual line of sight.

Networking 40

Networking San Diego Technology Research 40

Xconomy

SEPTEMBER 23, 2020

Libra Therapeutics is turning that research into potential therapies, and it now has $29 million to advance its work. Amyotrophic lateral sclerosis (ALS) has no cure and few available treatments but the past decade has revealed new knowledge about the pathology of the disease.

Research 114

Research San Diego Blogging Funding 114

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. billion , according to ArcView Market Research. The ArcView Group is a partner in CanopyBoulder).

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

OCTOBER 5, 2016

Defense Advanced Research Projects Agency—a famed military R&D group—wants to finance safety measures for the new gene-editing age. The idea for the funding program, called Safe Genes, is to get out ahead of problems that could bring the field to a screeching halt. Some see it as a way to eradicate malaria.)

Research 111

Research Technical Review Conference Software Review 111

Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. He helped turn a jellyfish protein into an invaluable lab tool that every researcher knows as “GFP”—green fluorescent protein, which is used to illuminate the inner workings of cells. He was a professor at UC San Diego.

News 57

News San Diego Journal Technical Review 57